Atlas Venture Life Science Advisors, LLC
Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Kymera Therapeutics, Inc.(KYMR) | 4,659,874 | 4,578,008 | -81,866 | 362,584,796 | 381,302,286 | 48.26% | +18,717,490 |
| Q32 Bio, Inc. | 2,092,106 | 2,092,106 | 0 | 6,945,792 | 13,431,321 | 1.70% | +6,485,529 |
| Korro Bio, Inc. | 1,137,149 | 1,137,149 | 0 | 9,108,563 | 12,872,527 | 1.63% | +3,763,964 |
| Sionna Therapeutics, Inc.(SION) | 2,995,602 | 2,995,602 | 0 | 123,239,066 | 120,093,684 | 15.20% | -3,145,382 |
| Generation Bio, Co. | 827,946 | 0 | -827,946 | 4,702,732 | 0 | — | -4,702,732 |
| Dyne Therapeutics, Inc.(DYN) | 9,130,465 | 9,130,465 | 0 | 178,591,895 | 165,535,330 | 20.95% | -13,056,565 |
| Disc Medicine, Inc.(IRON) | 1,513,875 | 1,513,875 | 0 | 120,216,814 | 96,797,168 | 12.25% | -23,419,646 |
| Day One Biopharmaceuticals, Inc. COM | 6,412,560 | 0 | -6,412,560 | 59,765,059 | 0 | — | -59,765,059 |